Structure | Chemical Name | CAS | MF |
|
2-Benzyl-5-nitroisoindoline
|
127168-68-7
|
C15H14N2O2
|
|
2-BENZYL-2,3-DIHYDRO-1H-ISOINDOL-5-YLAMINE
|
127168-70-1
|
C15H16N2
|
|
4-METHOXYISOINDOLINE
|
127168-73-4
|
C9H11NO
|
|
5-CHLOROISOINDOLINE HYDROCHLORIDE
|
127168-76-7
|
C8H8ClN
|
|
4-Chloro-1H-pyrrolo[3,2-c]pyridine
|
127168-78-9
|
C8H8FN
|
|
3-Bromo-1H-isoindoline
|
127168-81-4
|
C8H8BrN
|
|
1-broMo-2,3-bis(broMoMethyl)benzene
|
127168-82-5
|
C8H7Br3
|
|
4-Bromo-2-tosylisoindoline ,97%
|
127168-83-6
|
C15H14BrNO2S
|
|
5-BROMOISOINDOLINE
|
127168-84-7
|
C8H8BrN
|
|
4-NITROISOINDOLINE
|
127168-86-9
|
C8H8N2O2
|
|
5-METHOXY-2,3-DIHYDRO-1H-ISOINDOLE
|
127168-88-1
|
C9H11NO
|
|
B90102
|
127168-89-2
|
C16H17NO
|
|
Methyl isoindoline-4-carboxylate hydrochloride
|
127168-90-5
|
C10H12ClNO2
|
|
Methyl 2,3-bis(broMoMethyl)benzoate
|
127168-91-6
|
C10H10Br2O2
|
|
METHYL 2-BENZYLISOINDOLINE-4-CARBOXYLATE
|
127168-92-7
|
C17H17NO2
|
|
METHYL ISOINDOLINE-5-CARBOXYLATE HYDROCHLORIDE
|
127168-93-8
|
C10H12ClNO2
|
|
Methyl 2-benzylisoindoline-5-carboxylate
|
127168-94-9
|
C17H17NO2
|
|
isoindolin-4-ylMethanol
|
127168-95-0
|
C9H11NO
|
|
ISOINDOLIN-5-YLMETHANOL
|
127168-98-3
|
C9H11NO
|
|
(2-BENZYLISOINDOLIN-4-YL)METHANAMINE
|
127169-00-0
|
C16H18N2
|
|
2-BENZYLISOINDOLINE-4-CARBOXYLICACID
|
127169-17-9
|
C16H15NO2
|
|
8-Fluoro-2-Tetralone
|
127169-82-8
|
C10H9FO
|
|
2-hydroxy-3-(3H-imidazol-4-ylmethyl)-N-methyl-benzamide hydrochloride
|
127170-74-5
|
C12H14ClN3O2
|
|
2-hydroxy-3-[1-(3H-imidazol-4-yl)ethyl]benzamide hydrochloride
|
127170-75-6
|
C12H14ClN3O2
|
|
2-Hydroxy-3-(1H-imidazol-5-ylmethyl)-6-methylbenzamide Hydrochloride
|
127170-87-0
|
C12H14ClN3O2
|
|
N-(4-hydroxy-4-pyridin-3-yl-pentyl)-N-methyl-nitrous amide
|
127171-58-8
|
C11H17N3O2
|
|
Tetramethylammonium phthalate
|
127171-87-3
|
C16H28N2O4
|
|
1-(3,4-diMethoxyphenyl)-3-(diMethylaMino)prop-2-en-1-one
|
127172-22-9
|
C13H17NO3
|
|
K 259-3
|
127172-90-1
|
C22H20O7
|
|
TRIDECETH-4 CARBOXYLIC ACID
|
127174-97-4
|
C21H42O6
|
|
Methanesulfonic acid, trifluoro-, 2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)ethyl ester
|
127175-39-7
|
C11H8F3NO5S
|
|
1-Octadecanaminium, N,N-dimethyl-N-octadecyl-, salt with 4,4-(3,3-dichloro1,1-biphenyl-4,4-diyl)bisazo(2-acetyl-1-oxo-2,1-ethanediyl)iminobisbenzenesulfonic acid (2:1)
|
127179-40-2
|
C70H104Cl2N7O10S2-
|
|
3',4-O-dimethylcedrusin
|
127179-41-3
|
C21H26O6
|
|
Bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, 3-methyl-, (1S,2S,3R,4R)- (9CI)
|
127179-45-7
|
C9H12O2
|
|
1,2,3-Propanetriol, 1,2-diacetate, (S)-
|
127179-48-0
|
C7H12O5
|
|
4-O-DeMethylkadsurenin D
|
127179-70-8
|
C20H22O5
|
|
(1R,2S)-1-AMINO-2-(HYDROXYMETHYL)-CYCLOPROPANECARBOXYLIC ACID
|
127181-31-1
|
C5H9NO3
|
|
N-Desmethyl Clarithromycin (9E)-Oxime
|
127182-43-8
|
C37H68N2O13
|
|
ClarithroMycin IMpurity G
|
127182-44-9
|
C39H72N2O13
|
|
(3aS,6S)-7,7-Dichloro-4,5,6,7-tetrahydro-8,8-diMethyl-3H-3a,6-Methano-2,1-benzisothiazole 2,2-Dioxide
|
127184-04-7
|
C10H13Cl2NO2S
|
|
(+)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
|
127184-05-8
|
C10H13Cl2NO3S
|
|
4-C10-13-SECALKYLDERIVATIVESBENZENESULFONICACID,SODIUMSALT
|
127184-52-5
|
|
|
Cyclohexane, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-, homopolymer, caprolactam-blocked
|
127184-53-6
|
|
|
comB protein
|
127187-58-0
|
|
|
ling zhi 8
|
127187-71-7
|
|
|
4-BOC-1-(6-METHYL-2-PYRIDYL)PIPERAZINE
|
127188-33-4
|
C15H23N3O2
|
|
Hydrazinecarboxamide, N-2-benzothiazolyl- (9CI)
|
127188-39-0
|
C8H8N4OS
|
|
7-(deoxyguanosin-N(2)-yl)aristolactam I
|
127191-85-9
|
C27H22N6O8
|
|
7-(deoxyadenosin-N(6)-yl)aristolactam I
|
127191-86-0
|
C27H22N6O7
|
|
KN-62
|
127191-97-3
|
C38H35N5O6S2
|
|
3-(4,6-Difluortriazinylamino)-7-methoxycoumarin
|
127192-67-0
|
C13H8F2N4O3
|
|
4-(2-Quinoxalinyl-3-butene-1,2-diol
|
127196-36-5
|
C12H12N2O2
|
|
4-(2-NAPHTHYL)-1,3-DITHIOL-2-THIONE
|
127198-67-8
|
C13H8S3
|
|
3-Quinolinecarboxylic acid, 6,7-
difluoro-1-(2-fluorocyclopropyl)-1,4-
dihydro-4-oxo-, cis-(+)- (9CI)
|
127199-00-2
|
C13H8F3NO3
|
|
DU 6858
|
127199-06-8
|
C19H18ClF2N3O3
|
|
cis-2-fluorocyclopropyl)-N-((R)-1-phenylethyl)acetaMide
|
127199-12-6
|
C12H14FNO
|
|
(1R,2R)-2-fluorocyclopropanecarboxylic acid
|
127199-13-7
|
C4H5FO2
|
|
(1S,2S)-2-Fluorocyclopropanecarboxylic acid
|
127199-14-8
|
C4H5FO2
|
|
Carbamic acid, (2-fluorocyclopropyl)-, 1,1-dimethylethyl ester, (1S-cis)- (9CI)
|
127199-15-9
|
C8H14FNO2
|
|
Carbamic acid, (2-fluorocyclopropyl)-, 1,1-dimethylethyl ester, (1R-cis)- (9CI)
|
127199-16-0
|
C8H14FNO2
|
|
3-Quinolinecarboxylic acid, 8-chloro-6,7-difluoro-1-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo-
|
127199-27-3
|
C13H7ClF3NO3
|
|
Carbamic acid, (7R)-5-azaspiro[2.4]hept-7-yl-, 1,1-dimethylethyl ester (9CI)
|
127199-44-4
|
C11H20N2O2
|
|
Carbamic acid, (7S)-5-azaspiro[2.4]hept-7-yl-, 1,1-dimethylethyl ester (9CI)
|
127199-45-5
|
C11H20N2O2
|
|
tert-butyl (3S,4S)-4-Methylpyrrolidin-3-ylcarbaMate
|
127199-54-6
|
C10H20N2O2
|
|
tert-butyl (3R,4R)-4-Methylpyrrolidin-3-ylcarbaMate
|
127199-55-7
|
C10H20N2O2
|
|
BenzaMide, 3-(1-piperazinyl)-
|
127201-39-2
|
C11H15N3O
|
|
bis(imidazole)(5,10,15,20-tetraphenylporphinato)iron(III) bis(1,2-dicyanoethylenedithiolato)cuprate(III) tetrakis(tetrahydrofuran)
|
127203-07-0
|
C62H48CuFeN12OS4
|
|
2-PHENYL-BENZO[D]IMIDAZO[2,1-B]THIAZOLE-3-CARBOXALDEHYDE
|
127204-71-1
|
C16H10N2OS
|
|
2-(4-BROMO-PHENYL)-BENZO[D]IMIDAZO[2,1-B]THIAZOLE-3-CARBALDEHYDE
|
127204-72-2
|
C16H9BrN2OS
|
|
2-(4-METHOXY-PHENYL)-BENZO[D]IMIDAZO[2,1-B]THIAZOLE-3-CARBALDEHYDE
|
127204-73-3
|
C17H12N2O2S
|
|
FaMciclovir iMpurity 7
|
127205-22-5
|
C10H15N5O3
|
|
copper (II) ethylglyoxal bis(N(4)-methylthiosemicarbazone)
|
127207-06-1
|
C8H16CuN6S2+2
|
|
N-acetylglucosaminyl(beta1-3)-N-acetylglucosaminyl(1-6)-galactopyranosyl(1-4)-N-acetylglucosamine
|
127212-19-5
|
C30H51N3O21
|
|
1,3-Dioxolan-2-one, 4-(fluoroMethyl)- (Related Reference)
|
127213-73-4
|
C4H5FO3
|
|
1,3-Dioxolan-2-one,4,5-dichloro-,trans-(9CI)
|
127213-77-8
|
C3H2Cl2O3
|
|
1,3-Dioxolan-2-one,4,5-dichloro-,cis-(9CI)
|
127213-84-7
|
C3H2Cl2O3
|
|
CAMIGLIBOSE
|
127214-23-7
|
C13H25NO9
|
|
2-Hepten-4-one,6-[(1R,4R,5R)-4,5-dihydroxy-4-methyl-2-cyclohexen-1-yl]-2-methyl-, (6S)-
|
127214-86-2
|
C15H24O3
|
|
Intermedin B
|
127214-87-3
|
C15H22O2
|
|
dotriacontatetraenoic acid
|
127216-46-0
|
|
|
Ethanethioic acid, (naphthalenylamino)-, S-(5-(4,5-dihydro-4-((1H-indo l-3-yl)methylene)-2-methyl-5-oxo-1H-imidazol-1-yl)-1,3,4-thiadiazol-2- yl) ester
|
127216-76-6
|
C27H20N6O2S2
|
|
BenzenaMine, 2-iMidazo[1,2-a]pyridin-2-yl-
|
127219-06-1
|
C13H11N3
|
|
5-ETHOXYCARBONYLINDOLE-2-CARBOXYLIC ACID ETHYL ESTER
|
127221-02-7
|
C14H15NO4
|
|
AURORA 12
|
127221-07-2
|
C16H15NO3
|
|
(2S)-1-aMino-2-PyrrolidineMethanol
|
127221-89-0
|
C5H12N2O
|
|
2-(4-ISOBUTYLPHENYL)PROPANOHYDRAZIDE
|
127222-69-9
|
C13H20N2O
|
|
1,2-O-ISOPROPYLIDENE-3-S-HYDROXY-4-R-ETHYDINYL TETRAHYDROFURAN
|
127223-28-3
|
C9H12O4
|
|
1H-Pyrazole-1-ethanol, 3,4,5-trimethyl-
|
127223-53-4
|
C8H14N2O
|
|
(E)-4-(diMethylaMino)-1,1,1-trifluorobut-3-en-2-one
|
127223-93-2
|
C6H8F3NO
|
|
1,1,1-TRIFLUORO-4-ISOPROPYLAMINOPENT-3-EN-2-ONE
|
127223-95-4
|
C8H12F3NO
|
|
6-(2-phenylethyl)oximino naltrexone
|
127227-10-5
|
C28H32N2O4
|
|
6-(3-phenylpropyl)oximino naltrexone
|
127227-11-6
|
C29H34N2O4
|
|
(5E)-3-[5-(2-anilinoacetyl)sulfanyl-1,3,4-thiadiazol-2-yl]-5-(1H-indol -3-ylmethylidene)-2-methyl-imidazol-4-one
|
127227-37-6
|
C23H18N6O2S2
|
|
(5E)-5-(1H-indol-3-ylmethylidene)-2-methyl-3-[5-[2-[(2-methylphenyl)am ino]acetyl]sulfanyl-1,3,4-thiadiazol-2-yl]imidazol-4-one
|
127227-38-7
|
C24H20N6O2S2
|
|
(5E)-3-[5-[2-[(4-chlorophenyl)amino]acetyl]sulfanyl-1,3,4-thiadiazol-2 -yl]-5-(1H-indol-3-ylmethylidene)-2-methyl-imidazol-4-one
|
127227-40-1
|
C23H17ClN6O2S2
|
|
(5E)-5-(1H-indol-3-ylmethylidene)-2-methyl-3-[5-[2-[(3-nitrophenyl)ami no]acetyl]sulfanyl-1,3,4-thiadiazol-2-yl]imidazol-4-one
|
127227-41-2
|
C23H17N7O4S2
|
|
(5E)-5-(1H-indol-3-ylmethylidene)-3-[5-[2-[(4-methoxyphenyl)amino]acet yl]sulfanyl-1,3,4-thiadiazol-2-yl]-2-methyl-imidazol-4-one
|
127227-42-3
|
C24H20N6O3S2
|
|
3-(1,3-dioxolan-2-yl)-4-fluoro-Benzenamine
|
127228-82-4
|
C9H10FNO2
|
|
Minoxidil hydrochloride
|
127228-87-9
|
C9H16ClN5O
|
|
(9-fluorenylmethyl)ethylcarbonate
|
127228-99-3
|
|